Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06791226

Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms

Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/ CT in Patients With Orbital Neoplasms and Compared With 18F-FDG PET/ CT

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Peking University Third Hospital · Academic / Other
Sex
All
Age
3 Years – 80 Years
Healthy volunteers
Not accepted

Summary

To evaluate the potential usefulness of 18F-AlF-FAPI positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in orbital neoplasms, and compared with 18F-FDG PET/CT.

Detailed description

Subjects with orbital neoplasms underwent contemporaneous 18F-AlF-FAPI and 18F-FDG PET/CT for initial assessment. Tumor uptake was quantified by the maximum standard uptake value (SUVmax). The numbers of metastatic lesions of 18F-FDG and 18F-AlF-FAPI PET/CT were recorded by visual interpretation. The sensitivity, specificity, and accuracy of 18F-AlF-FAPI, 18F-FDG PET/CT were calculated and compared to evaluate the diagnostic accuracy.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TEST18F-AlF-FAPI PET/CT, 18F-FDG PET/CTSubjects with orbital neoplasms underwent contemporaneous 18F-AlF-FAPI and 18F-FDG PET/CT for diagnosis and staging.

Timeline

Start date
2024-07-16
Primary completion
2028-12-31
Completion
2028-12-31
First posted
2025-01-24
Last updated
2025-01-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06791226. Inclusion in this directory is not an endorsement.